276 related articles for article (PubMed ID: 23043594)
1. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
Morawski JH; Prüfert A; van Engen A; Foerster D; Sander-Struckmeier S; Małecka-Panas E; Pezzilli R
J Med Econ; 2012; 15 Suppl 1():15-25. PubMed ID: 23043594
[TBL] [Abstract][Full Text] [Related]
2. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.
Thorat V; Reddy N; Bhatia S; Bapaye A; Rajkumar JS; Kini DD; Kalla MM; Ramesh H
Aliment Pharmacol Ther; 2012 Sep; 36(5):426-36. PubMed ID: 22762290
[TBL] [Abstract][Full Text] [Related]
3. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
[TBL] [Abstract][Full Text] [Related]
4. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
Kuhn RJ; Gelrud A; Munck A; Caras S
Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
[TBL] [Abstract][Full Text] [Related]
5. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
Ramesh H; Reddy N; Bhatia S; Rajkumar JS; Bapaye A; Kini D; Kalla M; Thorat V
Pancreatology; 2013; 13(2):133-9. PubMed ID: 23561971
[TBL] [Abstract][Full Text] [Related]
6. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency.
Sander-Struckmeier S; Beckmann K; Janssen-van Solingen G; Pollack P
Pancreas; 2013 Aug; 42(6):983-9. PubMed ID: 23587850
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
[TBL] [Abstract][Full Text] [Related]
9. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.
Seiler CM; Izbicki J; Varga-Szabó L; Czakó L; Fiók J; Sperti C; Lerch MM; Pezzilli R; Vasileva G; Pap A; Varga M; Friess H
Aliment Pharmacol Ther; 2013 Apr; 37(7):691-702. PubMed ID: 23383603
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
Wu B; Chen H; Shen J; Ye M
Clin Ther; 2011 Oct; 33(10):1446-55. PubMed ID: 21992806
[TBL] [Abstract][Full Text] [Related]
11. [The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study].
Bideeva TV; Maev IV; Kucheryavyy YA; Andreev DN; Shah YS; Lobanova EG; Zaborovskiy AV; Levchenko AI
Ter Arkh; 2020 Jan; 92(1):30-35. PubMed ID: 32598660
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life.
D'Haese JG; Ceyhan GO; Demir IE; Layer P; Uhl W; Löhr M; Rychlik R; Pirilis K; Zöllner Y; Gradl B; Foerster D; Möbius J; Henniges F; Friess H
Pancreas; 2014 Aug; 43(6):834-41. PubMed ID: 24717829
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
Whitcomb DC; Bodhani A; Beckmann K; Sander-Struckmeier S; Liu S; Fuldeore M; Pollack PF; Khurmi RP
Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784
[TBL] [Abstract][Full Text] [Related]
14. Exocrine pancreatic insufficiency following esophagectomy.
Huddy JR; Macharg FM; Lawn AM; Preston SR
Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
[TBL] [Abstract][Full Text] [Related]
16. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
Knop FK; Vilsbøll T; Lund A; Krarup T; Holst JJ; Hornum M
JOP; 2010 Sep; 11(5):489-91. PubMed ID: 20818126
[No Abstract] [Full Text] [Related]
17. Pancreatic enzyme supplementation.
Wier HA; Kuhn RJ
Curr Opin Pediatr; 2011 Oct; 23(5):541-4. PubMed ID: 21799412
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic enzyme pharmacotherapy.
Ferrone M; Raimondo M; Scolapio JS
Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
[TBL] [Abstract][Full Text] [Related]
19. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use.
Lindkvist B; Phillips ME; Domínguez-Muñoz JE
Pancreatology; 2015; 15(6):589-97. PubMed ID: 26243045
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
